These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 868902

  • 1. Gentamicin/amikacin-resistant gram-negative bacilli at Detroit General Hospital, 1975-1976.
    Jauregui L, Cushing RD, Lerner AM.
    Am J Med; 1977 Jun; 62(6):882-8. PubMed ID: 868902
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
    Block CS, Fabian B, Robinson RG.
    S Afr Med J; 1978 Mar 18; 53(11):396-99. PubMed ID: 675374
    [Abstract] [Full Text] [Related]

  • 4. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
    Moellering RC, Wennersten C, Kunz LJ, Poitras JW.
    Am J Med; 1977 Jun 18; 62(6):873-81. PubMed ID: 868901
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA, Farrell W, Maskell J, Williams JD.
    Br Med J; 1976 Nov 27; 2(6047):1284-7. PubMed ID: 1000196
    [Abstract] [Full Text] [Related]

  • 7. Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates.
    Forgan-Smith WR, McSweeney RJ.
    Aust N Z J Med; 1978 Aug 27; 8(4):383-6. PubMed ID: 282852
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R, Hajsig D, Babić I, Mostovac D.
    Lijec Vjesn; 1978 Nov 27; 100(11):708-10. PubMed ID: 107386
    [No Abstract] [Full Text] [Related]

  • 14. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S, Vera D, Ramírez-Ronda CH.
    Am J Med; 1986 Jun 30; 80(6B):65-70. PubMed ID: 3014877
    [Abstract] [Full Text] [Related]

  • 15. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL, Alvarez S, Ortega G, Verghese A, Holtsclaw-Berk SA.
    Arch Intern Med; 1986 Mar 30; 146(3):538-41. PubMed ID: 3954526
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of gentamicin- and amikacin-resistant bacteria in sink drains.
    Perryman FA, Flournoy DJ.
    J Clin Microbiol; 1980 Jul 30; 12(1):79-83. PubMed ID: 7419703
    [Abstract] [Full Text] [Related]

  • 17. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
    Ruiz-Palacios GM, Ponce de Leon S, Sifuentes J, Ponce de Leon S, Calva JJ, Huazano F, Ontiveros C, Ojeda F, Bobadilla M.
    Am J Med; 1986 Jun 30; 80(6B):71-5. PubMed ID: 3089006
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
    Acar JF, Witchitz JL, Goldstein F, Talbot JN, Le Goffic F.
    J Infect Dis; 1976 Nov 30; 134 SUPPL():S280-5. PubMed ID: 825587
    [Abstract] [Full Text] [Related]

  • 20. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J, Thomas M, Shanmugam J.
    Indian J Pathol Microbiol; 1985 Apr 30; 28(2):115-9. PubMed ID: 3835114
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.